AnGes, Inc.
Notice of Recording non-operating income, non-operating expenses, extraordinary gains, extraordinary losses and adjustments of corporate taxes, etc.
For the six-month period from January 1, 2026 to June 30, 2026, accruals for interest received from bank deposits, foreign exchange gains, outsourcing fees, bond interest, stock issuance costs, reversals of stock options, impairment of fixed assets, and write-down of deferred tax assets were recorded. Details will be disclosed in the earnings press release.
Key Figures
- Interest income received: 4,536千円
- Foreign exchange gains: 682,515千円
- Outsourcing fees: 3,545千円
- Bond interest: 14,387千円
- Stock issuance costs: 2,922千円
- Reversal of stock option amendments: 5,168千円
- Impairment loss on fixed assets: 58,147千円
- Adjustments of corporate taxes, etc.: 4,293千円
AI要約
Section heading
This is a notice regarding the recognition of non-operating income/expenses and corporate tax adjustments for the second quarter of the consolidated period ending December 2026 (the six months from January 1, 2026 to June 30, 2026). Key items include interest income received, foreign exchange gains, reclassification from deferred revenue to revenue, bond interest, stock issuance costs, reversal of stock option adjustments due to retirement, impairment of fixed assets for EmendoBio, Inc., and the write-down of deferred tax assets. Details will be disclosed in the earnings press release.
Second section heading
Since the impact of this period is not yet defined, details will be disclosed in future consolidated earnings press releases. Exchange rate effects and impairment charges may be temporary factors, and investors should refer to the earnings press release for the second quarter of the fiscal year ending December 2026.
Anges Co., Ltd.
Company overview · Stock price · Financial data · All IR
